Slovenian Intellectual Property Office SIPO Database Server Guide

 Hit 204 out of 284 selected records
 Patent lapsed
(51)Int. Cl.:
C07D 471/00   A61K 31/00   A61P 35/00   
(11)Publication Number:3004090
(21)Application Number:201430531
(22)Application Date:27.05.2014
(86)PCT Application:27.05.2014 WO PCT/GB2014/051607
(96)EP Application:27.05.2014 EP 14727036.7 European patent register
(87)PCT Publication:WO 2014/191726, 04.12.2014 Patentscope
(97)EP Publication: EP 3004090 B1, 25.10.2017 European publication server PDF
(30)Priority:28.05.2013 US 201361827951 P;
13.12.2013 US 201361915685 P
(46)Claims Published:31.01.2018 (T1 - Translation of claims of European patent) PDF
(72)Inventor:AKHTAR Nadim, Macclesfield Cheshire SK10 2NA, GB (United Kingdom);
BRADBURY Robert Hugh, Macclesfield Cheshire SK10 4TG, GB (United Kingdom);
BUTTAR David, Macclesfield Cheshire SK10 2NA, GB (United Kingdom);
CURRIE Gordon Stuart, Macclesfield Cheshire SK10 2NA, GB (United Kingdom);
DE SAVI Christopher, Waltham, Massachusetts 02451, US (United States);
DONALD Craig Samuel, Macclesfield Cheshire SK10 4TG, GB (United Kingdom);
NORMAN Richard Albert, Macclesfield Cheshire SK10 4TG, GB (United Kingdom);
OSBORNE Matthew, Macclesfield Cheshire SK10 2NA, GB (United Kingdom);
RABOW Alfred Arthur, Cheshire SK10 4TG, GB (United Kingdom);
REDFEARN Heather Marie, Macclesfield Cheshire SK10 2NA, GB (United Kingdom);
WILLIAMS Helen Elizabeth, Macclesfield Cheshire SK10 2NA, GB (United Kingdom);
YAVARI Neda, Macclesfield Cheshire SK10 2NA, GB (United Kingdom)
(73)Owner:AstraZeneca AB,
151 85 Soedertaelje, SE (Sweden)
(74)Representative:MARK-INVENTA d.o.o.,
Glinska 14, 1000 Ljubljana, SI (Slovenia)
(54)Title:CHEMICAL COMPOUNDS
Additional information: 
 Filed by SIPO on 18.12.2017
 Patent in force until 27.05.2020